Value Partners Investments Inc.

Position in LLY — ELI LILLY & Co

CIK 1800916 WINNIPEG, A2

Position in LLY

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$3,569,503

+$794,557 QoQ

Shares Held

2,976

-1.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#1,985

of 4,605 holders

Holding Since

Jun 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Value Partners Investments Inc. holds $22,889,378 across 5 Drug Manufacturers - General names. LLY ranks #3 (15.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	58,251	$11,045,554
2	PFE	Pfizer Inc	164,000	$3,949,120
3	LLY	ELI LILLY & Co This page	2,976	$3,569,503
4	MRK	Merck & Co., Inc.	18,475	$2,374,037
5	NVS	Novartis AG	12,450	$1,951,164

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,569,503	2,976	-1.4%	Shares	Sole	2026-07-15
2026-03-31	$2,774,946	3,017	+5.6%	Shares	Sole	2026-04-21
2025-12-31	$3,070,361	2,857	-11.8%	Shares	Sole	2026-01-08
2025-09-30	$2,471,357	3,239	+0.5%	Shares	Sole	2025-10-15
2025-06-30	$2,513,204	3,224	+10.8%	Shares	Sole	2025-07-07
2025-03-31	$2,404,224	2,911	-90.3%	Shares	Sole	2025-04-23
2020-09-30	$4,425,205	29,896	+177.4%	Shares	Sole	2020-11-05
2020-06-30	$1,769,203	10,776	—	Shares	Sole	2020-07-30
No filing history on record for this holder in this stock.